UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 381

Sortiert nach

Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection

Proceedings of the National Academy of Sciences - PNAS, 2021-02, Vol.118 (5), p.1

2021

Volltextzugriff (PDF)

Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

Journal of medicinal chemistry, 2010-03, Vol.53 (6), p.2443-2463

2010

Volltextzugriff (PDF)

Molecular Modeling Based Approach to Potent P2−P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease

Journal of the American Chemical Society, 2008-04, Vol.130 (14), p.4607-4609

2008

Volltextzugriff (PDF)

Electrochemiluminescence assay for basic carboxypeptidases: inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitor

Analytical biochemistry, 2003-08, Vol.319 (1), p.159-170

2003

Volltextzugriff (PDF)

A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3–4A protease at low enzyme concentrations

Analytical biochemistry, 2008-02, Vol.373 (1), p.1-8

2008

Volltextzugriff (PDF)

Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P 1 ′ group

Bioorganic & medicinal chemistry letters, 2004-05, Vol.14 (9), p.2141-2145

2004

Volltextzugriff (PDF)

Selective Inhibition of Factor Xa in the Prothrombinase Complex by the Carboxyl-terminal Domain of Antistasin

The Journal of biological chemistry, 1998-11, Vol.273 (46), p.30086-30091

1998

Volltextzugriff (PDF)

Reaction pathway for inhibition of blood coagulation factor Xa by tick anticoagulant peptide

Biochemistry (Easton), 1992-06, Vol.31 (23), p.5374-5380

1992

Volltextzugriff (PDF)

Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient mice

Blood coagulation & fibrinolysis, 2005-09, Vol.16 (6), p.407-415

2005

Volltextzugriff (PDF)

Synthesis and Evaluation of Imidazole Acetic Acid Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor as Novel Antithrombotics

Journal of medicinal chemistry, 2003-12, Vol.46 (25), p.5294-5297

2003

Volltextzugriff (PDF)

Stereochemical correlation of proclavaminic acid and syntheses of erythro- and threo-L-.beta.-hydroxyornithine from an improved vinylglycine synthon

Journal of organic chemistry, 1991-01, Vol.56 (2), p.728-731

1991

Volltextzugriff (PDF)

Miniaturizable homogenous time-resolved fluorescence assay for carboxypeptidase B activity

Analytical biochemistry, 2003-06, Vol.317 (1), p.94-98

2003

Volltextzugriff (PDF)

Characterization of Plasmin-mediated Activation of Plasma Procarboxypeptidase B

The Journal of biological chemistry, 1999-12, Vol.274 (49), p.35046-35052

1999

Volltextzugriff (PDF)

Characterization of the two-step pathway for inhibition of thrombin by alpha-ketoamide transition state analogs

The Journal of biological chemistry, 1998-02, Vol.273 (9), p.4843-4854

1998

Volltextzugriff (PDF)

Inhibition of thrombin by peptides containing Lysyl-alpha-keto carbonyl derivatives

Thrombosis and haemostasis, 1995-10, Vol.74 (4), p.1107

1995

Volltextzugriff (PDF)

Identification and Characterization of Variants of Tick Anticoagulant Peptide with Increased Inhibitory Potency toward Human Factor Xa

Biochemistry (Easton), 1995-04, Vol.34 (15), p.5098-5103

1995

Volltextzugriff (PDF)

Factor Xa inhibitors

Perspectives in drug discovery and design, 1994-04, Vol.1 (3), p.423-430

Mao, Shi-Shan

1994

Volltextzugriff (PDF)

Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans

The Journal of biological chemistry, 1999-12, Vol.274 (49), p.35046

1999

Volltextzugriff (PDF)

Clavulanic acid biosynthesis: the stereochemical course of β-lactam formation from chiral glycerol

Journal of the Chemical Society. Chemical communications, 1987 (2), p.86-89

1987

Volltextzugriff (PDF)

The stereochemical fate of (2RS,5R)- and (2RS,5S)-[5-3H]ornithine in clavulanic acid biosynthesis

Journal of the Chemical Society. Chemical communications, 1986 (8), p.638-639

1986

Volltextzugriff (PDF)

Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 Position

Journal of medicinal chemistry, 1997-11, Vol.40 (23), p.3726-3733

1997

Volltextzugriff (PDF)

Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P(1)(') group

Bioorganic & medicinal chemistry letters, 2004-05, Vol.14 (9), p.2141-2145

2004

Volltextzugriff (PDF)

Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P'1 group

Bioorganic & medicinal chemistry letters, 2004, Vol.14 (9), p.2141-2145

2004

Volltextzugriff (PDF)

Corrosion Behavior of S450EW Low-alloy Weathering Steel in Cyclically Alternate Corrosion Environments

Journal of iron and steel research, international, 2015-11, Vol.22 (11), p.1020-1023

2015

Volltextzugriff (PDF)

Molecular Modeling Based Approach to Potent P2-P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease

Journal of the American Chemical Society, 2008-01, Vol.130 (14), p.4607-4609

2008

Volltextzugriff (PDF)

1 – 25 von 381

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(319)
Mit Volltextzugriff
(352)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(218)
Life Sciences & Biomedicine
(144)
Humans
(80)
Animals
(57)
Physical Sciences
(56)
Female
(42)
Male
(35)
Chemistry
(33)
Physics
(29)
Science & Technology - Other Topics
(29)
Technology
(28)
Adult
(22)
Biochemistry & Molecular Biology
(22)
Mice
(22)
Oncology
(21)
Chemistry, Multidisciplinary
(20)
Materials Science
(20)
Middle Aged
(18)
Multidisciplinary Sciences
(17)
China
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection

Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

Molecular Modeling Based Approach to Potent P2−P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease

Electrochemiluminescence assay for basic carboxypeptidases: inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitor

A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3–4A protease at low enzyme concentrations

Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P 1 ′ group

Selective Inhibition of Factor Xa in the Prothrombinase Complex by the Carboxyl-terminal Domain of Antistasin

Reaction pathway for inhibition of blood coagulation factor Xa by tick anticoagulant peptide

Demonstration of enhanced endogenous fibrinolysis in thrombin activatable fibrinolysis inhibitor-deficient mice

Synthesis and Evaluation of Imidazole Acetic Acid Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor as Novel Antithrombotics

Stereochemical correlation of proclavaminic acid and syntheses of erythro- and threo-L-.beta.-hydroxyornithine from an improved vinylglycine synthon

Miniaturizable homogenous time-resolved fluorescence assay for carboxypeptidase B activity

Characterization of Plasmin-mediated Activation of Plasma Procarboxypeptidase B

Characterization of the two-step pathway for inhibition of thrombin by alpha-ketoamide transition state analogs

Inhibition of thrombin by peptides containing Lysyl-alpha-keto carbonyl derivatives

Identification and Characterization of Variants of Tick Anticoagulant Peptide with Increased Inhibitory Potency toward Human Factor Xa

Factor Xa inhibitors

Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans

Clavulanic acid biosynthesis: the stereochemical course of β-lactam formation from chiral glycerol

The stereochemical fate of (2RS,5R)- and (2RS,5S)-[5-3H]ornithine in clavulanic acid biosynthesis

Discovery of a Novel, Selective, and Orally Bioavailable Class of Thrombin Inhibitors Incorporating Aminopyridyl Moieties at the P1 Position

Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P(1)(') group

Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P'1 group

Corrosion Behavior of S450EW Low-alloy Weathering Steel in Cyclically Alternate Corrosion Environments

Molecular Modeling Based Approach to Potent P2-P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease

Suchergebnisse filtern